Search Login Register

4-acetoxy-13-((3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate Summary

Description: an antineoplastic agent; structure in first source

Also Known As: cabazitaxel; jevtana

Networked: 183 relevant articles (37 outcomes, 49 trials/studies) for this Drug

Key Diseases for which 4-acetoxy-13-((3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate is Relevant

  1. Prostatic Neoplasms (Prostate Cancer) : 26 outcomes 29 studies in 150 results
  2. Neoplasms (Cancer) : 7 outcomes 14 studies in 29 results
  3. Neoplasm Metastasis (Metastasis) : 3 outcomes 3 studies in 8 results
  4. Breast Neoplasms (Breast Cancer) : 1 outcome 4 studies in 8 results
  5. Disease Progression : 1 outcome 2 studies in 6 results
Show All >>

Drugs Related to 4-acetoxy-13-((3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate

  1. docetaxel (Taxotere)
  2. abiraterone
  3. sipuleucel-T (APC8015)
  4. Prednisone (Sone)
  5. taxane
  6. Mitoxantrone (Novantrone)
  7. denosumab
  8. Hormones
  9. Prednisolone (Predate)
  10. capecitabine (Xeloda)
Show All >>

Therapies Related to 4-acetoxy-13-((3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate

  1. Castration
  2. Drug Therapy (Chemotherapy)
  3. Immunotherapy
  4. Heterologous Transplantation (Xenotransplantation)
  5. Therapeutics
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.